318 related articles for article (PubMed ID: 9580744)
1. Toremifene and letrozole for advanced breast cancer.
Med Lett Drugs Ther; 1998 Apr; 40(1024):43-5. PubMed ID: 9580744
[No Abstract] [Full Text] [Related]
2. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
3. [Aromatase inhibitors: anastrozole versus tamoxifen as first-ine therapy for advanced postmenopausal breast cancer].
Bergmann L
Strahlenther Onkol; 2001 May; 177(5):273-4. PubMed ID: 11398617
[No Abstract] [Full Text] [Related]
4. New treatment option for postmenopausal women with early breast cancer.
Expert Rev Anticancer Ther; 2002 Dec; 2(6):617. PubMed ID: 12503198
[No Abstract] [Full Text] [Related]
5. The Letrozole Breast Cancer Trial: clinical implications and remaining questions.
Chen WY; Manson JE
Womens Health Issues; 2004; 14(1):7-10. PubMed ID: 15001182
[No Abstract] [Full Text] [Related]
6. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Miller WR; Stuart M; Sahmoud T; Dixon JM
Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
[TBL] [Abstract][Full Text] [Related]
7. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Roseman BJ; Buzdar AU; Singletary SE
J Surg Oncol; 1997 Nov; 66(3):215-20. PubMed ID: 9369969
[TBL] [Abstract][Full Text] [Related]
8. Focus on anastrozole and breast cancer.
Mokbel K
Curr Med Res Opin; 2003; 19(8):683-8. PubMed ID: 14687437
[TBL] [Abstract][Full Text] [Related]
9. New breast cancer drug.
Brink S
US News World Rep; 2001 Dec; 131(26):52. PubMed ID: 11793594
[No Abstract] [Full Text] [Related]
10. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
[TBL] [Abstract][Full Text] [Related]
11. [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].
Illiger HJ
Strahlenther Onkol; 2002 Feb; 178(2):111-3. PubMed ID: 11942036
[No Abstract] [Full Text] [Related]
12. Letrozole improves disease-free survival vs tamoxifen in adjuvant treatment of early breast cancer.
Oncology (Williston Park); 2005 Mar; 19(3):277, 360. PubMed ID: 15828547
[No Abstract] [Full Text] [Related]
13. Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001.
Munster PN; Horton J
Cancer Control; 2001; 8(6):478-9. PubMed ID: 11807416
[No Abstract] [Full Text] [Related]
14. A better medication for treating breast cancer?
Johns Hopkins Med Lett Health After 50; 2002 May; 14(3):3. PubMed ID: 12004835
[No Abstract] [Full Text] [Related]
15. The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women.
Buzdar AU; Vergote I; Sainsbury R
Breast J; 2004; 10(3):211-7. PubMed ID: 15125747
[TBL] [Abstract][Full Text] [Related]
16. [Antiestrogen therapy in the treatment of breast neoplasms].
Alba E; Ragonesi G; Colla F; Mazzoleni A; Farina C
Minerva Ginecol; 2002 Jun; 54(3):245-51. PubMed ID: 12063440
[TBL] [Abstract][Full Text] [Related]
17. [Campaign against breast cancer. Are aromatase inhibitors the better choice? (interview by Dr. Dorothea Dlugosch)].
Bruntsch U
MMW Fortschr Med; 2002 Sep; 144(38):20. PubMed ID: 12395697
[No Abstract] [Full Text] [Related]
18. [Two new therapeutic principles in the management of breast cancer and colorectal cancer: selective oral aromatase inhibition and thymidilate synthase inhibition].
Internist (Berl); 1997 Mar; 38(3 Suppl Selektive):1-16. PubMed ID: 9541667
[No Abstract] [Full Text] [Related]
19. Letrozole in breast cancer.
Shahab N
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971058
[No Abstract] [Full Text] [Related]
20. Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer.
Zabolotny BP; Zalai CV; Meterissian SH
J Surg Oncol; 2005 Apr; 90(1):26-30. PubMed ID: 15786432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]